Insiders Trades
Medistim ASA Stock: price and insider trades · Norway
No insider purchase over the last 90 days. The latest was filed 27 Jan 2025.
Medistim ASA: what insiders have been doing
This page follows insider dealings at Medistim ASA as filed with Oslo Børs, a company from the Healthcare & Pharma sector. 6 insiders have disclosed 7 filings since 18 October 2025.
All open-market trades in the period are sales: 2 sales, by 2 insiders, with no purchase on record. The amount is not disclosed for 2 filings.
A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
With 7 filings in twelve months, the company is more active than the median of 4 filings across the 257 companies we follow on the same exchange. Our records for Medistim ASA go back to 2021, with 2 purchases and 9 sales on the open market in total.
For comparison within the same sector, see the insider buying recorded at MAIA Biotechnology, Inc. and Cooper Companies, Inc. These figures are compiled from regulatory filings published by Oslo Børs. They describe what insiders did and are not a recommendation.
Insider Decl.
37
Thresholds
n/a
Buy Volume
€933,681
2 ops. · all time
Sell Volume
€839,905
9 ops. · all time
Who traded when
BuySaleA. Brøymer2 buys
Chief Business Development1 sale
Mike Karim1 sale
New Chief Research1 sale
Since the insiders bought
- +46.0%Entry NOK 155.50 · Close at T+365 NOK 227.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Fundamental score
Ranked 4,769 of 24,148 companies
66.9
score / 100
Value43
Quality91
FCF yld3.0%
Earn yld3.1%
EV/EBITDA21.8x
ROE42%
Gross mgn82%
Net mgn23%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
NOK 281.00
Analyst consensus
2 analysts1.00/5
NOK 325.00Target NOK 332.50(+18%)NOK 340.00
Income statement
RevenueNOK 699.8M
Gross profitNOK 571.6M82% margin
EBITDANOK 237.9M34% margin
Net incomeNOK 159.2M22.0% margin
Valuation
PER (trailing)31.1x
PER (forward)27.0x
P/Book12.5x
Beta0.95
Balance sheet & cash
Market capNOK 5.1B
Total debtNOK 49.3M
Free Cash FlowNOK 154.1M
Debt / Equity8%
Profitability & ownership
ROE41.6%
ROA23.0%
% insiders20.2%
% institutions55.5%
Last declaration on 2 September 2026
Declarations37 total
ShareXOSLOSLO:670905
ShareXOSLOSLO:670854
3,772 sharesShareXOSLOSLO:659281
2,211 sharesShareXOSLOSLO:659161
619 sharesShareXOSLOSLO:649744
@ €15.056ShareXOSLOSLO:647875
70,000 shares@ NOK 178.632817.9% of flowShareXOSLOSLO:644332
66,460 shares@ NOK 179.546516.8% of flowShareXOSLOSLO:643962
61,382 shares@ NOK 180.997315.6% of flowShareXOSLOSLO:643675
52,181 shares@ NOK 183.822514.3% of flowShareXOSLOSLO:643088
42,543 shares@ NOK 186.143111.9% of flowShareXOSLOSLO:642822
42,543 shares@ NOK 186.143111.9% of flowShareXOSLOSLO:642557
27,543 shares@ NOK 187.94797.7% of flowShareXOSLOSLO:641988
14,000 shares@ NOK 189.01673.9% of flowShareXOSLOSLO:641375
860,735 sharesShareXOSLOSLO:640373
45,000 shares@ NOK 146.0059.9% of flowShareXOSLOSLO:637214
Canonical exit: 27 Apr 2025 (T+90)
30,000 shares@ NOK 147.0040.1% of flowShareXOSLOSLO:636197
Canonical exit: 9 Apr 2025 (T+90)
ShareXOSLOSLO:632775
1,240 sharesShareXOSLOSLO:625692
400 sharesShareXOSLOSLO:622703
25 of 37 declarations
About Medistim ASA
Medistim ASA is a Norwegian company specializing in the development of medical technologies for cardiac surgery. It is listed on the Oslo Stock Exchange, XOSL.
